OrbiMed Advisors

OrbiMed Advisors is a prominent investment firm specializing in the healthcare and biotechnology sectors. With over 25 years of experience, the firm manages approximately $19 billion in assets across public and private investments worldwide. Their global team of over 130 professionals operates across multiple locations, including New York City, London, San Francisco, Shanghai, Hong Kong, Mumbai, and Herzliya, enabling the firm to provide tailored financing solutions and extensive resources to its portfolio companies.

The firm's investment approach spans various stages of company development, from seed-stage startups to large multinational corporations, focusing on biopharmaceuticals, medical devices, diagnostics, and technology-enabled healthcare services. OrbiMed's portfolio includes a diverse range of companies, such as ADARx, Treeline Biosciences, Caris Life Sciences, Mirador Therapeutics, Biokin, and Avenzo Therapeutics.

OrbiMed's commitment to healthcare innovation is evident in its extensive portfolio and global presence, reflecting its dedication to advancing the healthcare industry through strategic investments and partnerships.